Open AccessEfficacy, Pharmacokinetics, and Safety Over 48 Weeks With Ibalizumab-Based Therapy in Treatment-Experienced Adults Infected With HIV-1: A Phase 2a Study
Author(s) -
Joseph Gathe,
Robin L Hardwicke,
Fernando García,
Steven P. Weinheimer,
Stanley T. Lewis,
Robert Brandon Cash
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002591
Subject(s) - placebo , medicine , regimen , pharmacokinetics , viral load , gastroenterology , human immunodeficiency virus (hiv) , surgery , immunology , pathology , alternative medicine